Bronchiolitis Obliterans: all 82 studies

Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLADRecruitingNCT07434869
• Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem CellsRecruitingNCT07239895Early Phase 1
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 2
• Bronchial Epithelium of Children With Post-infectious Bronchiolitis ObliteransRecruitingNCT06140901Not applicable
• Evaluating Bronchodilator Response in Patients With BronchiectasisRecruitingNCT05932316Not applicable
• BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)RecruitingNCT05922761Phase 2
• Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans SyndromeRecruitingNCT04604522
• TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT PatientsRecruitingNCT04098445
• Measures of Respiratory Health (MRH)RecruitingNCT02657837
• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)CompletedNCT03657342Phase 3Results posted
• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)CompletedNCT03656926Phase 3Results posted
• Hp129 Xenon Imaging and BOS in Lung TransplantationCompletedNCT03603899Phase 1/2Results posted
• Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant RecipientsCompletedNCT01650545Phase 1/2Results posted
• Targeted Therapy of Bronchiolitis Obliterans SyndromeCompletedNCT01307462Phase 2Results posted
• Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans SyndromeCompletedNCT01287078Phase 2Results posted
• Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransCompletedNCT01273207Phase 2Results posted
• Respiratory Impedance and Obliterative BronchiolitisCompletedNCT01255449Not applicableResults posted
• A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHDTerminatedNCT01163786Phase 2Results posted
• Bronchodilator Responsiveness in Obliterative BronchiolitisCompletedNCT01112241Phase 4Results posted
• Montelukast to Treat Bronchiolitis ObliteransCompletedNCT00656058Phase 2Results posted
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell TransplantCompletedNCT00141726Phase 2Results posted
• TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSActive, not recruitingNCT07316829
• High Intensity Intervallic Training in Children With Bronchiolitis ObliteransCompletedNCT05881538Not applicable
• Efficacy and Safety of Azithromycin in Patients With Bronchiolitis ObliteransCompletedNCT05299567Phase 4
• Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell TransplantTerminatedNCT04908735Phase 2
• COVID-19 Pathophysiology of Long Term ImplicationsStatus unknownNCT04813575Not applicable
• Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre TransplantationTerminatedNCT04655508Phase 3
• A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of ItacitinibTerminatedNCT04640025Phase 2
• 4DX for the Diagnosis of Constrictive BronchiolitisCompletedNCT04489758Not applicable
• Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell TransplantTerminatedNCT04239989Phase 1
• Study of Pulmonary MRI for the Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Stem Cell TransplantationCompletedNCT04080232Not applicable
• Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)TerminatedNCT04039347Phase 3
• Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPCStatus unknownNCT04029636
• INSPIRE Continuation Post-Approval StudyCompletedNCT03868904
• Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell TransplantationCompletedNCT03805477Phase 2
• The Safety and Tolerability of Pirfenidone for BOS After HCTCompletedNCT03315741Phase 1
• Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)CompletedNCT03237364Early Phase 1
• Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow TransplantationCompletedNCT02902471Not applicable
• Macitentan in the Treatment of Organ Rejection After Lung TransplantationWithdrawnNCT02893176Phase 4
• Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BOStatus unknownNCT02627833
• MSC for Treatment of Interstitial Lung Disease After Allo-HSCTStatus unknownNCT02543073Phase 1/2
• LCI and Bronchial Inflammation in Patients With BOCompletedNCT02495597
• Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)TerminatedNCT02488304Phase 2
• Microparticles and Bronchiolitis Obliterans SyndromeCompletedNCT02458274
• Transplant Optimization Using Functional Imaging (TROFI)CompletedNCT02441413Not applicable
• Transplant Optimization Using Functional ImagingCompletedNCT02364674Not applicable
• European Trial of Pirfenidone in BOS, A European Multi-center StudyCompletedNCT02262299Phase 2/3
• Mesenchymal Stem Cell Therapy for Lung RejectionCompletedNCT02181712Phase 1
• Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3WithdrawnNCT02109237Not applicable
• Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.CompletedNCT02032381Not applicable
• A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCTStatus unknownNCT01639261Phase 2
• Bronchial Inflammation in Patients With Bronchiolithis ObliteransCompletedNCT01633385
• Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell TransplantationCompletedNCT01560689Phase 2
• Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS)TerminatedNCT01439958Phase 3
• Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post AllotransplantTerminatedNCT01432080Phase 2
• Tacrolimus Versus Cyclosporine for Immunosuppression After Lung TransplantationCompletedNCT01429844Phase 3
• L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) PatientsTerminatedNCT01334892Phase 2/3
• Efficacy Study of Azithromycin-based Therapy for Bronchiolitis ObliteransTerminatedNCT01327625Not applicable
• Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis ObliteransCompletedNCT01327248
• Vitamin D in Bronchiolitis Obliterans SyndromeCompletedNCT01212406Phase 4
• Montelukast in Bronchiolitis Obliterans SyndromeCompletedNCT01211509Phase 4
• Immune Mediated Disorders After Allogeneic Hematopoietic Cell TransplantationCompletedNCT01206309
• A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung TransplantationCompletedNCT01175655Phase 1
• Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT StudyStatus unknownNCT00980967Not applicable
• CIS001 Extension Study of Cyclosporine Inhalation SolutionTerminatedNCT00938236Phase 3
• Viral Triggers in Pediatric Lung TransplantationCompletedNCT00891865
• Immune Mechanisms of Rejection in Human Lung AllograftsCompletedNCT00861900
• Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung TransplantationCompletedNCT00755781Phase 3
• Long-Term Study On Home Spirometry After Lung TransplantationCompletedNCT00743171
• Surveillance Study of Viral Infections Following Lung TransplantationCompletedNCT00701922
• Cyclosporine Inhalation Solution (CIS) in Lung Transplant RecipientsNo longer availableNCT00633373
• Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCTCompletedNCT00624754Phase 2
• Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow TransplantationCompletedNCT00563251Not applicable
• Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung TransplantationTerminatedNCT00502554Not applicable
• Immunosuppressive Therapy With Certican (Everolimus) After Lung TransplantationCompletedNCT00402532Phase 3
• Use of Clarithromycin in Mustard-Induced BronchiolitisCompletedNCT00381147Phase 3
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans SyndromeStatus unknownNCT00378677Early Phase 1
• Use of Erythromycin in Mustard-Induced BronchiolitisCompletedNCT00367419Phase 4
• Prospective Evaluations of Infectious Complication in Lung Transplant RecipientsCompletedNCT00177918
• Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory DiseaseStatus unknownNCT00163696
• Etanercept for Non-Infectious Lung Injury Following Bone Marrow TransplantationCompletedNCT00029328Phase 1/2
• Popcorn Lung: the Discovery of a New DiseaseCompletedNCT00027235

← Bronchiolitis Obliterans overview